GlassScriptPhysician profile
John W Lindberg
NPI 1174681050
$2,509.13
in general payments reported to CMS, 2019-2025
9 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $161 · 2021: $165 · 2022: $284 · 2023: $285 · 2024: $814 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637 · Travel and Lodging: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.73 |
| Travel and Lodging | $632.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,112.19 | 2019-2025 | Grafix, Collagenase Santyl, Renasys Touch |
| Zimmer Biomet Holdings, INC. | $632.15 | 2024 | Advantagerib |
| Stryker Corporation | $355.70 | 2019 | |
| Convatec INC. | $203.13 | 2019-2023 | |
| Reapplix INC. | $117.20 | 2022 | |
| Radius Health, INC. | $35.00 | 2019 | |
| Acera Surgical, INC. | $21.30 | 2022 | |
| Hartmann USA, INC. | $21.29 | 2022 | |
| Organogenesis INC. | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lindberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.